JORGE E CORTES to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications JORGE E CORTES has written about TOR Serine-Threonine Kinases.
Connection Strength
0.096
-
Protein profiling identifies mTOR pathway modulation and cytostatic effects of Pim kinase inhibitor, AZD1208, in acute myeloid leukemia. Leuk Lymphoma. 2016 12; 57(12):2863-2873.
Score: 0.082
-
Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis. Leuk Lymphoma. 2010 Feb; 51(2):269-74.
Score: 0.013